Characterization of ovarian cancer long-term responders on olaparib.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Stephanie Lheureux, Jonathan A. Ledermann, Stanley B. Kaye, Charlie Gourley, Michael Friedlander, David Bowtell, Jacques De Greve, Anna deFazio, Ronnie Shapira-Frommer, Johann Sebastian De Bono, M. William Audeh, Elise C. Kohn, Kathryn Alsop, Clare L. Scott, Ursula Matulonis, Bella Kaufman, Brent Burger, Jane D Robertson, Tony Ho, Amit M. Oza
Institutions: Princess Margaret Cancer Centre, University College London, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Royal Marsden Hospital, Edinburgh Cancer Research, Prince of Wales Hospital, Peter MacCallum Cancer Centre, Universitair Ziekenhuis Brussel, The University of Sydney, Westmead Institute, Tel Aviv University, Sheba Medical Center, Cedars-Sinai Medical Center, National Institutes of Health, National Cancer Institute, The Royal Melbourne Hospital, Dana-Farber Cancer Institute, AstraZeneca (United Kingdom), AstraZeneca (United States), University Health Network
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2605350705